Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Long-Term Investments (2021 - 2025)

U S Physical Therapy's Long-Term Investments history spans 3 years, with the latest figure at $12.3 million for Q3 2023.

  • For Q3 2023, Long-Term Investments rose 2.32% year-over-year to $12.3 million; the TTM value through Sep 2023 reached $12.3 million, up 2.32%, while the annual FY2022 figure was $12.1 million, 0.69% down from the prior year.
  • Long-Term Investments for Q3 2023 was $12.3 million at U S Physical Therapy, roughly flat from $12.2 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $12.4 million in Q1 2022 and bottomed at $12.0 million in Q3 2022.
  • The 3-year median for Long-Term Investments is $12.2 million (2021), against an average of $12.2 million.
  • The largest YoY upside for Long-Term Investments was 2.32% in 2023 against a maximum downside of 2.11% in 2023.
  • A 3-year view of Long-Term Investments shows it stood at $12.2 million in 2021, then decreased by 0.69% to $12.1 million in 2022, then grew by 1.03% to $12.3 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Long-Term Investments are $12.3 million (Q3 2023), $12.2 million (Q2 2023), and $12.2 million (Q1 2023).